Trial Radar KI | ||
|---|---|---|
Die klinische Studie NCT07278037 für Postpartale Blutung, Geburtskomplikation, Kaiserschnittkomplikationen, Perinatale Probleme ist offene rekrutierung. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen. | ||
Eine Studie entspricht den Filterkriterien
Kartenansicht
Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage 648 Postpartal
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT07278037 ist eine beobachtungsstudie zur Untersuchung von Postpartale Blutung, Geburtskomplikation, Kaiserschnittkomplikationen, Perinatale Probleme und hat den Status offene rekrutierung. Die Studie startete am 1. Dezember 2025 und soll 648 Teilnehmer aufnehmen. Durchgeführt von Mahidol-Universität ist der Abschluss für 30. September 2026 geplant. Die Daten von ClinicalTrials.gov wurden zuletzt am 22. Dezember 2025 aktualisiert.
Kurzbeschreibung
Postpartum hemorrhage (PPH) is the global leading cause of maternal death, with 20-30% of maternal deaths in Thailand linked to hemorrhage. The WOMAN Trial (2017) provided strong evidence that administering tranexamic acid (TXA)within three hours of bleeding onset lowered PPH-related mortality by 31%. Consequently, the World Health Organization (WHO) updated its guidelines, recommending TXA as part of the standard tr...Mehr anzeigen
Ausführliche Beschreibung
Postpartum hemorrhage (PPH) is the foremost global cause of maternal mortality and represents a critical public health challenge. While the frequency of PPH varies worldwide, its prevalence remains markedly higher in developing nations. For instance, in Thailand, maternal death rates were reported between 20.0 and 40.5 per 100,000 deliveries from 1990 to 2015, with PPH accounting for 20% to 30% of these fatalities. S...Mehr anzeigen
Offizieller Titel
A Retrospective Analysis of the Longitudinal Pattern of Tranexamic Acid Administration in Parturients Undergoing Cesarean Delivery Complicated by Postpartum Hemorrhage
Erkrankungen
Postpartale BlutungGeburtskomplikationKaiserschnittkomplikationenPerinatale ProblemeWeitere Studien-IDs
- 776/2568(IRB3)
- Si 717/2025 (Andere Kennung) (Faculty of Medicine Siriraj Hospital Mahidol University)
NCT-Nummer
Studienbeginn (tatsächlich)
2025-12-01
Zuletzt aktualisiert
2025-12-22
Studienende (vorauss.)
2026-09-30
Geplante Rekrutierung
648
Studientyp
Beobachtungsstudie
Status
Offene Rekrutierung
Stichwörter
cesarean delivery
complications
postpartum hemorrhage
tranexamic acid
complications
postpartum hemorrhage
tranexamic acid
Studienarme/Interventionen
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
Tranexamic acid group Patients received tranexamic acid after postpartum hemorrhage | Tranexamic acid The number of patients received tranexamic acid after postpartum hemorrhage |
Non tranexamic acid group Patients did not receive tranexamic acid after postpartum hemorrhage | Nicht zutreffend |
Hauptergebnismessungen
Nebenergebnismessungen
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Rate of tranexamic acid administration divided by year | Number of patients received tranexamic acid after diagnosis of postpartum hemorrhage | Within 24 hours after delivery |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Quantity of blood loss | Quantity of blood loss recorded in patients chart | Within 24 hours after delivery |
Number of patients received blood transfusion | Number of patients received packed red cells transfusion | Within 24 hours after delivery |
Number of patients received additional obstetrical interventions | Number of patients received additional obstetrical interventions such as intrauterine balloon insertion, hysterectomy, uterine artery ligation, B-lynch suture | Within 24 hours after delivery |
Number of patients receive reoperation | Reoperation within 24 hours after cesarean delivery | Within 24 hours after delivery |
Causes of postpartum hemorrhage | Causes of postpartum hemorrhage divided into 4 categories, 1: uterine atony; 2: abnormal placentation; 3: trauma to internal organ(s); 4:abnormal coagulation | Within 24 hours after delivery |
Factors influencing tranexamic acid administration | Identify factors influencing tranexamic acid administration eg. history of antepartum hemorrhage, placental cause of PPH etc. | Within 24 hours after delivery |
Side effect of tranexamic acid administration | Side effect of tranexamic acid administration eg. thromboembolism, stroke | After delivery to 30 days |
Hospital length of stay | Hospital length of stay in days | After delivery to 30 days |
Maternal Mortality | Maternal death rate if death occur | After delivery to 30 days |
Teilnahme-Assistent
Eignungskriterien
Zugelassene Altersgruppen
Kind, Erwachsene, Ältere Erwachsene
Zugelassene Geschlechter
Weiblich
- 1. Patients underwent cesarean delivery with primary postpartum hemorrhage
- Gestational age at less than 24 weeks
- Absence of the anesthetic record
- Received tranexamic acid in the antepartum period
- Blood loss less than 1,000 ml
Zentrale Studienkontakte
Kontakt: Patchareya Nivatpumin, M.D., +66896662187, [email protected]
Kontakt: Premyuda Matangkarat, M.D., +66959472598, [email protected]
1 Studienstandorte in 1 Ländern
Bangkok
Siriraj Hospital, Bangkoknoi, Bangkok, 10700, Thailand
Patchareya Nivatpumin, M.D., Kontakt, +66896662187, [email protected]
Premyuda Matangkarat, M.D., Kontakt, +66959472598, [email protected]
Offene Rekrutierung